why choose us

First received: August 28, 2024

Clinical Trial: Contrast-Associated Nephropathy Risk Evaluation in Acute Ischemic Stroke After Endovascular Thrombectomy

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Contrast-Associated Acute Kidney Injury

Study Type: OBSERVATIONAL


Official Title: CAN-REST: Contrast-Associated Nephropathy Risk Evaluation in Acute Ischemic Stroke After Endovascular Thrombectomy

Brief Summary: The CAN-REST study is a multicenter, observational, and retrospective study aimed at evaluating the incidence and risk factors of contrast-associated acute kidney injury (CA-AKI) in patients with acute ischemic stroke (AIS) who undergo endovascular thrombectomy (EVT).This study is conducted across multiple centers in Italy, Europe, the USA, and Canada, and includes data from AIS patients treated with EVT in 2023.The primary objectives are to assess the incidence of CA-AKI in this population and identify associated…

Read more